<DOC>
	<DOCNO>NCT02396316</DOCNO>
	<brief_summary>To assess efficacy safety administration aflibercept intravitreal injection comparison sham control intraocular pressure patient neovascular glaucoma .</brief_summary>
	<brief_title>Japanese Phase 3 Study Aflibercept Neovascular Glaucoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Neovascular</mesh_term>
	<criteria>Japanese men woman age 20 year old , Patients diagnose Neovascular glaucoma ( NVG ) neovascularization anterior segment ( iris anterior chamber angle ) , Patients Intraocular pressure ( IOP ) high 25 mmHg study eye due anterior segment ( iris anterior chamber angle ) neovascularization . Patients angleclosure due condition Neovascular glaucoma Patients know suspected ocular periocular infection , Patients severe intraocular inflammation study eye , Women pregnant , suspect pregnant lactating , Patients know allergy aflibercept .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>